GlassScriptPhysician profile
Bruce N Kramer
NPI 1952570996
$3,574.39
in general payments reported to CMS, 2019-2025
27 companies · $73.00 in 2025
The $73.00 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $998 · 2020: $457 · 2021: $572 · 2022: $761 · 2023: $374 · 2024: $340 · 2025: $73.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $786.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $786.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $627.78 | 2019-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $610.58 | 2019-2023 | Jublia |
| Smith+Nephew, INC. | $540.76 | 2019-2024 | Collagenase Santyl, Grafix |
| Paratek Pharmaceuticals, INC. | $291.39 | 2021-2025 | Nuzyra |
| Melinta Therapeutics, LLC | $268.44 | 2019 | |
| Organogenesis INC. | $234.90 | 2019-2024 | Puraply |
| Depuy Synthes Sales INC. | $174.93 | 2022-2025 | Healix Knotless Peek, Dynacord, Dynatape |
| Paragon 28, INC. | $107.07 | 2019 | |
| Medtronic, INC. | $89.46 | 2023-2024 | Intellis Adaptivestim |
| Bard Peripheral Vascular, INC. | $77.26 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $74.49 | 2022-2023 | Seglentis |
| Pfizer INC. | $70.77 | 2020-2021 | |
| Next Science LLC | $44.22 | 2023-2024 | Xperience, Blastx, Surgx |
| Kerecis Limited | $43.77 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Kci USA, INC. | $40.45 | 2019-2023 | Activ.A.C. |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nvision Biomedical Technologies, INC. | $35.48 | 2024 | Trigon |
| Nabriva Therapeutics, Plc | $30.66 | 2022 | |
| Abbott Laboratories | $28.45 | 2024 | Eterna |
| Pacira Pharmaceuticals Incorporated | $26.46 | 2024 | Exparel |
| Averitas Pharma INC. | $24.29 | 2023 | Qutenza |
| Novus Surgical Consultants | $23.16 | 2024 | |
| Zimvie INC. | $22.27 | 2022 | |
| Guard Medical INC. | $18.43 | 2024 | Npseal Large |
| Bioventus LLC | $17.72 | 2024 | Exogen Ultrasound Bone Healing System |
| Solventum Corporation | $17.53 | 2025 | V.A.C.Ulta, V.A.C. Veraflo Cleanse Choice, Prevena |
| Dynasplint Systems INC. | $17.15 | 2022 | |
| Stimwave Technologies Incorporated | $16.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Kramer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.